Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14356/2318
Title: | Guillain Barre Syndrome after vaccination against Corona Virus Disease19: Managed in limited resource setting |
Authors: | Kamar, Sher Bahadur Bhatta, Uttam Kumar Singh, Ratna Timilsana, Manju Paudel |
Citation: | KamarS. B., BhattaU. K., SinghR., & Paudel TimilsanaM. (2023). Guillain Barre Syndrome after vaccination against Corona Virus Disease19: Managed in limited resource setting. Journal of Nepal Health Research Council, 20(4), 1013-1015. https://doi.org/10.33314/jnhrc.v20i4.4134 |
Issue Date: | 2022 |
Publisher: | Government of Nepal; Nepal Health Research Council; Ramshah Path, Kathmandu, Nepal |
Article Type: | Case Report |
Keywords: | Complication COVID-19 Guillain barre syndrome Vaccine |
Series/Report no.: | Oct-Dec, 2022;4134 |
Abstract: | Abstract A 16-year-old boy who classically featured Guillain Barre Syndrome (GBS) after Corona Virus Disease-19 vaccination was timely treated successfully in limited resource setting in far western province. After Moderna (mRNA COVID 19 Vaccine) vaccination, he rapidly developed ascending paralysis of limbs without autonomic and sensory or cranial nerve involvement. He has been treated with Intravenous Immuno-Globulin (IVIG). Over six-weeks long observation and supportive care and he was discharged with full recovery. Many GBS cases after vaccination have been reported but yet to know the association of vaccine. It is very important to address the complication for successful vaccination programme. Keywords: Complication; COVID-19; guillain barre syndrome; vaccine |
Description: | Case Report |
URI: | https://hdl.handle.net/20.500.14356/2318 |
ISSN: | Print ISSN: 1727-5482; Online ISSN: 1999-6217 |
Appears in Collections: | Vol 20 No 04 Issue 57 Oct-Dec, 2022 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
4134-Manuscript-32189-1-10-20230720.pdf | Fulltext. | 347.03 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.